These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 26219281)

  • 21. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
    Sorensen SV; Frick KD; Wade A; Simko R; Burge R
    Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the Effectiveness of Individually Tailored Lifestyle Intervention in Patients With Familial Hypercholesterolemia.
    Beyece İncazli S; Özer S; Kayikçioğlu M
    J Cardiovasc Nurs; 2022 Sep-Oct 01; 37(5):465-474. PubMed ID: 35952313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of nurse practitioner management of hypercholesterolemia following coronary revascularization.
    Paez KA; Allen JK
    J Am Acad Nurse Pract; 2006 Sep; 18(9):436-44. PubMed ID: 16958775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of a Home-Exercise Program Among Older People After Hospitalization.
    Farag I; Howard K; Hayes AJ; Ferreira ML; Lord SR; Close JT; Vogler C; Dean CM; Cumming RG; Sherrington C
    J Am Med Dir Assoc; 2015 Jun; 16(6):490-6. PubMed ID: 25703448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of a quality improvement collaborative focusing on patients with diabetes.
    Schouten LM; Niessen LW; van de Pas JW; Grol RP; Hulscher ME
    Med Care; 2010 Oct; 48(10):884-91. PubMed ID: 20808258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can multiple lifestyle behaviours be improved in people with familial hypercholesterolemia? Results of a parallel randomised controlled trial.
    Broekhuizen K; van Poppel MN; Koppes LL; Kindt I; Brug J; van Mechelen W
    PLoS One; 2012; 7(12):e50032. PubMed ID: 23251355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of a primary care intervention to treat obesity.
    Tsai AG; Wadden TA; Volger S; Sarwer DB; Vetter M; Kumanyika S; Berkowitz RI; Diewald LK; Perez J; Lavenberg J; Panigrahi ER; Glick HA
    Int J Obes (Lond); 2013 Aug; 37 Suppl 1(0 1):S31-7. PubMed ID: 23921780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of a cascade screening program for the early detection of familial hypercholesterolemia.
    Lázaro P; Pérez de Isla L; Watts GF; Alonso R; Norman R; Muñiz O; Fuentes F; Mata N; López-Miranda J; González-Juanatey JR; Díaz-Díaz JL; Blasco AJ; Mata P
    J Clin Lipidol; 2017; 11(1):260-271. PubMed ID: 28391894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Challenges in the health economics of familial hypercholesterolemia.
    Norman R; Watts GF; Weintraub W; Gidding SS
    Curr Opin Lipidol; 2016 Dec; 27(6):563-569. PubMed ID: 27798488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Precision of blood cholesterol measurement and high blood cholesterol case-finding and treatment.
    Weissfeld JL; Holloway JJ
    J Clin Epidemiol; 1992 Sep; 45(9):971-84. PubMed ID: 1432026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lifestyle intervention for hypercholesterolemic children. Is it worth it?
    Puzo J
    Clin Investig Arterioscler; 2020; 32(2):63-65. PubMed ID: 32171436
    [No Abstract]   [Full Text] [Related]  

  • 32. Effectiveness of a tailored behavioral intervention to improve hypertension control.
    Egan BM
    Hypertension; 2015 Feb; 65(2):273-5. PubMed ID: 25403609
    [No Abstract]   [Full Text] [Related]  

  • 33. Groups Urge a Return to LDL-C Monitoring as a Quality Metric.
    Kuehn BM
    Circulation; 2023 Nov; 148(22):1812-1813. PubMed ID: 38011242
    [No Abstract]   [Full Text] [Related]  

  • 34. The UK Paediatric Familial Hypercholesterolaemia Register: preliminary data.
    Ramaswami U; Cooper J; Humphries SE;
    Arch Dis Child; 2017 Mar; 102(3):255-260. PubMed ID: 26948823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An economic evaluation alongside a randomized controlled trial evaluating an individually tailored lifestyle intervention compared with usual care in people with familial hypercholesterolemia.
    Broekhuizen K; van Wier MF; Koppes LL; Brug J; van Mechelen W; Bosmans JE; van Poppel MN
    BMC Res Notes; 2015 Jul; 8():317. PubMed ID: 26219281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of Evolocumab in Patients With High Cardiovascular Risk in Spain.
    Villa G; Lothgren M; Kutikova L; Lindgren P; Gandra SR; Fonarow GC; Sorio F; Masana L; Bayes-Genis A; Hout BV
    Clin Ther; 2017 Apr; 39(4):771-786.e3. PubMed ID: 28366593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness analysis of alternative screening and treatment strategies for heterozygous familial hypercholesterolemia in the United States.
    Chen CX; Hay JW
    Int J Cardiol; 2015 Feb; 181():417-24. PubMed ID: 25569270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cascade screening based on genetic testing is cost-effective: evidence for the implementation of models of care for familial hypercholesterolemia.
    Ademi Z; Watts GF; Pang J; Sijbrands EJ; van Bockxmeer FM; O'Leary P; Geelhoed E; Liew D
    J Clin Lipidol; 2014; 8(4):390-400. PubMed ID: 25110220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of a distance lifestyle counselling programme among overweight employees from a company perspective, ALIFE@Work: a randomized controlled trial.
    Gussenhoven AH; van Wier MF; Bosmans JE; Dekkers JC; van Mechelen W
    Work; 2013 Jan; 46(3):337-46. PubMed ID: 23324710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No significant improvement of cardiovascular disease risk indicators by a lifestyle intervention in people with familial hypercholesterolemia compared to usual care: results of a randomised controlled trial.
    Broekhuizen K; van Poppel MN; Koppes LL; Kindt I; Brug J; van Mechelen W
    BMC Res Notes; 2012 Jul; 5():181. PubMed ID: 22490761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.